Drug intelligence / Profile preview

allogeneic bone marrow-derived mesenchymal stem cells (Cleveland Clinic)

Development stage
Unknown
Lead developer
Cleveland Clinic
Modality
Stem Cell Therapies → Cell Therapies
Administration
Submucosal, Endoscopic Injection
01

Overview

This investigational cell therapy, developed by The Cleveland Clinic, consists of allogeneic bone marrow-derived mesenchymal stem cells (MSCs) for the treatment of medically refractory pouchitis. The treatment involves a submucosal endoscopic injection of 60 million cells into the ileal pouch of patients who have undergone proctocolectomy with ileal pouch-anal anastomosis (IPAA) for chronic ulcerative colitis. The therapy is designed to leverage the anti-inflammatory and regenerative properties of MSCs to alter the local inflammatory milieu and the ileal pouch microbiome. It is currently being evaluated in a Phase I clinical trial (NCT05578508) to assess safety and feasibility.

Other names
MSCsmesenchymal stem cellsallogeneic bone marrow derived mesenchymal stem cells

Beyond the preview

Go deeper on allogeneic bone marrow-derived mesenchymal stem cells (Cleveland Clinic).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic bone marrow-derived mesenchymal stem cells (Cleveland Clinic).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call